These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35397003)

  • 21. DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers.
    Jin M; Matsumoto S; Ayaki T; Yamakado H; Taguchi T; Togawa N; Konno A; Hirai H; Nakajima H; Komai S; Ishida R; Chiba S; Takahashi R; Takao T; Hirotsune S
    Nat Commun; 2022 Nov; 13(1):6880. PubMed ID: 36371400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-Synuclein upregulates bim-mediated apoptosis by negatively regulating endogenous GCN5.
    Azam S; Kim IS; Choi DK
    Aging (Albany NY); 2022 Oct; 14(20):8292-8301. PubMed ID: 36309909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage NAD+ biosynthetic pathway enzymes moonlight as molecular chaperones to protect against proteotoxicity.
    Pinkerton M; Ruetenik A; Bazylianska V; Nyvltova E; Barrientos A
    Hum Mol Genet; 2021 May; 30(8):672-686. PubMed ID: 33749726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Contribution of
    Longhena F; Faustini G; Missale C; Pizzi M; Spano P; Bellucci A
    Neural Plast; 2017; 2017():5012129. PubMed ID: 28133550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease.
    Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS
    Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
    Luna E; Luk KC
    FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against α-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells.
    McCarthy E; Barron A; Morales-Prieto N; Mazzocchi M; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
    Mol Neurobiol; 2022 May; 59(5):2745-2757. PubMed ID: 35175558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria.
    Felici R; Lapucci A; Ramazzotti M; Chiarugi A
    PLoS One; 2013; 8(10):e76938. PubMed ID: 24155910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.
    Akrioti E; Karamitros T; Gkaravelas P; Kouroupi G; Matsas R; Taoufik E
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
    Kawahata I; Bousset L; Melki R; Fukunaga K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α-Synuclein modulates neurite outgrowth by interacting with SPTBN1.
    Lee HJ; Lee K; Im H
    Biochem Biophys Res Commun; 2012 Aug; 424(3):497-502. PubMed ID: 22771809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
    Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
    Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.
    Bobela W; Aebischer P; Schneider BL
    Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemical biology of NAD
    Icso JD; Thompson PR
    Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.